Floatz logo

Therapeutic Asset Ratings

4,361 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cediranib
Ovarian Carcinoma
National Cancer Institute (NCI)P3BB (64)
Cediranib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P3BB (64)
Cyclophosphamide
Cancer
National Cancer Institute (NCI)P3BB (64)
Cyclophosphamide
Hematologic Malignancies
National Cancer Institute (NCI)P3BB (64)
Cyclophosphamide
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)P3BB (64)
Cyclophosphamide
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P3BB (64)
Cytosin-Arabinosid
Myeloid Leukemia Associated With Down Syndrome
National Cancer Institute (NCI)P3BB (64)
ERIBULIN MONOMETHANESULFONATE
Invasive Breast Carcinoma
National Cancer Institute (NCI)P3BB (64)
Inno-206
Down Syndrome
National Cancer Institute (NCI)P3BB (64)
INTERFERON ALFA-2B
Cutaneous Melanoma
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Anal Margin Squamous Cell Carcinoma
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Anal Squamous Cell Carcinoma
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Anal Canal Squamous Cell Carcinoma
National Cancer Institute (NCI)P3BB (64)
Obinutuzumab
Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P3BB (64)
Procarbazine
Hodgkins Lymphoma
National Cancer Institute (NCI)P3BB (64)
Recombinant Human Hyaluronidase
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)P3BB (64)
TAMOXIFEN
Ductal Breast Carcinoma In Situ
National Cancer Institute (NCI)P3BB (64)
THIOGUANINE ANHYDROUS
Down Syndrome
National Cancer Institute (NCI)P3BB (64)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-
Central Nervous System Neoplasm
National Cancer Institute (NCI)P2BB (64)
5-azacytidine
Carcinoma, Non-Small Cell Lung
National Cancer Institute (NCI)P2BB (64)
azd6244
Cutaneous Melanoma
National Cancer Institute (NCI)P2BB (64)
cc-5013
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P2BB (64)
Showing 426 to 450 of 4,361 assets
PreviousPage 18 of 175Next